对有效诱导细胞增殖的信号动机进行表型选
Kirato Umene1, Teruyuki Nagamune1, Masahiro Kawahara2,3
1Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan.
Scientific reports
|September 20, 2023
概括
科学家们设计了受体,通过选氨酸基因组来控制细胞增殖. 这种新的现象型选方法在活细胞中使细胞命运的精确人工控制成为可能.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 细胞增殖是细胞发展和疾病的基本命运.
- 人工控制细胞增殖对于治疗和工业应用至关重要.
- 细胞因子受体信号转导受到铁素基因氨基酸序列的严重影响.
研究的目的:
- 开发一种表型选方法来选择诱导细胞增殖的氨酸基因.
- 设计能够以多种模式激活信号分子的受体.
- 为了证明活细胞中氨酸基因的第一个表型选.
主要方法:
- 创建了一个为工程接收器随机选择的氨酸图案的合成图书馆.
- 采用表型选方法直接选择诱导细胞增殖的动机.
- 通过将它们的诱导增殖能力与本地受体域进行比较,验证了所选的基因.
主要成果:
- 成功选择了诱导细胞增殖的氨酸基因.
- 选择的基因表现出与原生受体细胞质信号域相比的增殖水平.
- 这种模式选系统被证明适用于对细胞因子敏感的细胞.
结论:
- 开发了一种用于活细胞中氨酸基因的表型查的新方法.
- 这种方法允许通过受体工程人工控制细胞增殖.
- 开辟了信号传导工程在控制细胞命运的新途径.
更多相关视频
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.2K
07:18A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
Published on: May 12, 2017
6.5K
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
